Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6599
-0.0202 (-2.97%)
At close: May 30, 2025, 4:00 PM
0.6700
+0.0101 (1.53%)
After-hours: May 30, 2025, 7:59 PM EDT
Immunic Employees
Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.
Employees
91
Change (1Y)
14
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$1,059,297
Market Cap
63.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
IMUX News
- 2 days ago - Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - PRNewsWire
- 3 days ago - Immunic, Inc. Announces Proposed Public Offering - PRNewsWire
- 4 weeks ago - Immunic to Participate in Scientific and Industry Conferences in May - PRNewsWire
- 4 weeks ago - Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial - PRNewsWire
- 4 weeks ago - Immunic: A Strong Buy With Imminent Data Readout That Should Send Shares Higher - Seeking Alpha
- 7 weeks ago - Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - PRNewsWire
- 7 weeks ago - Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - PRNewsWire
- 2 months ago - Immunic, Inc. to Participate in Scientific and Industry Conferences in April - PRNewsWire